Urinary calcium excretion in primary hyperparathyroidism: Relationship to 25-hydroxyvitamin D status

Endocrine Practice

Volumn 11, Issue 1, 2005, Pages 37-42

  Bussey, Aaron D ^a   Bruder, Jan M ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; PARATHYROID HORMONE; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE; VITAMIN D;

CALCIUM EXCRETION; CALCIUM URINE LEVEL; DISEASE ASSOCIATION; ESTROGEN THERAPY; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; HYPERPARATHYROIDISM; PREVALENCE; REVIEW; VITAMIN D DEFICIENCY; ADULT; AGED; ARTICLE; BLOOD; CASE REPORT; FEMALE; MALE; MIDDLE AGED; URINE;

ADULT; AGED; AGED, 80 AND OVER; CALCIUM; FEMALE; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM; MALE; MIDDLE AGED; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 23644439221     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.11.1.37     Document Type: Review

References (15)

1. Silverberg SJ, Shane E, Dempster DW, Bilezikian JP. The effects of vitamin D insufficiency in patients with primary hyperparathyroidism. Am J Med. 1999;107:561-567.
2. Bandeira F, Caldas G, Freese E, Griz L, Faria M, Bandeira C. Relationship between serum vitamin D status and clinical manifestations of primary hyperparathyroidism. Endocr Pract. 2002;8:266-270.
3. Bilezikian J. Primary hyperparathyroidism. In: Favus MJ, ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 4th ed. Philadelphia, PA: Lippincott, Williams & Wilkins, 1999: 187-192.
4. Bringhurst FR, Demay MB, Kronenberg HM. Hormones and disorders of mineral metabolism. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR, eds. Williams Textbook of Endocrinology. 9th ed. Philadelphia, PA: WB Saunders, 1998: 1155-1209.
5. Bilezikian J, Silverberg S. Primary hyperparathyroidism: epidemiology and clinical consequences. Clin Rev Bone Miner Metab. 2002; 1:25-34.
6. Bilezikian JP, Potts JT Jr, Fuleihan G-H, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Bone Miner Res. 2002;17(Suppl 2):N2-N11.
7. Fuleihan G-H. Familial benign hypocalciuric hypercalcemia. J Bone Miner Res. 2002;17(Suppl 2):N51-N56.
8. Tannenbaum C, Clark J, Schwartzman K, et al. Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J Clin Endocrinol Metab. 2002;87:4431-4437.
9. Mezquita-Raya P, Munoz-Torres M, Luna JD, et al. Relation between vitamin D insufficiency, bone density, and bone metabolism in healthy postmenopausal women. J Bone Miner Res. 2001;16:1408-1415.
10. Malabanan A, Veronikis IE, Hollick MF. Redefining vitamin D insufficiency [letter]. Lancet. 1998;351:805-806.
11. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001;22:477-501.
12. Romagnoli E, Caravella P, Scarnecchia L, Martinez P, Minisola S. Hypovitaminosis D in an Italian population of healthy subjects and hospitalized patients. Br J Nutr. 1999; 81:133-137.
13. Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med. 1998;338:777-783.
14. Sherman SS, Hollis BW, Tobin JD. Vitamin D status and related parameters in a healthy population: the effects of age, sex, and season. J Clin Endocrinol Metab. 1990;71: 405-413.
15. Harris SS, Dawson-Hughes B. Seasonal changes in plasma 25-hydroxyvitamin D concentrations of young American black and white women. Am J Clin Nutr. 1998; 67:1232-1236.